Back to discover
Drug

Xylazine

Research stage
Emerging research

Also known as AnaSed, Rompun, Xilazina, Xylazinum.

RxNorm1099660ChEMBLCHEMBL297362UNII2KFG9TP5V8
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Xylazine
Aliases & brands
AnaSedRompunXilazinaXylazinum
RxNorm CUI
1099660
ChEMBL ID
CHEMBL297362
UNII
2KFG9TP5V8

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes5
Anesthesia1Brain1Hemodynamics1Neurovascular Coupling1Wakefulness1
Journals, researchers & institutions
Top journals
  • Cell reports1
Leading researchers
  • Bauer AQ1
  • Bice AR1
  • Goyal MS1
  • Kim B1
  • Lee JM1
  • Macauley SL1
  • Padawer-Curry JA1
  • Rosenthal ZP1
Leading institutions
free-text, unnormalised
  • Boston University1
  • University of Kentucky1
  • University of Pennsylvania Health System Penn Medicine1
  • Washington University in Saint Louis1
  • Washington University School of Medicine1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Ketamine

Frequently co-studied with Xylazine in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature